• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响乳酸乳球菌中表达的破伤风毒素片段C免疫原性的因素。

Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.

作者信息

Norton P M, Brown H W, Wells J M, Macpherson A M, Wilson P W, Le Page R W

机构信息

Department of Pathology, University of Cambridge, UK.

出版信息

FEMS Immunol Med Microbiol. 1996 Jun;14(2-3):167-77. doi: 10.1111/j.1574-695X.1996.tb00284.x.

DOI:10.1111/j.1574-695X.1996.tb00284.x
PMID:8809553
Abstract

The relative immunogenicity of tetanus toxin fragment C (TTFC) has been determined in three different strains of inbred mice when expressed in Lactococcus lactis as a membrane-anchored protein (strain UCP1054), as an intracellular protein (strain UCP1050), or as a secreted protein which is partly retained within the cell wall (strain UCP1052). Protection against toxin challenge (20 x LD50) could be obtained without the induction of anti-lactococcal antibodies. When compared in terms of the dose of expressed tetanus toxin fragment C required to elicit protection against lethal challenge the membrane-anchored form was significantly (10-20 fold) more immunogenic than the alternative forms of the protein.

摘要

已在三种不同品系的近交系小鼠中测定了破伤风毒素片段C(TTFC)的相对免疫原性,该片段在乳酸乳球菌中分别作为膜锚定蛋白(UCP1054菌株)、细胞内蛋白(UCP1050菌株)或部分保留在细胞壁内的分泌蛋白(UCP1052菌株)表达。无需诱导抗乳球菌抗体即可获得针对毒素攻击(20×LD50)的保护。就引发针对致死性攻击的保护所需的表达破伤风毒素片段C的剂量而言,膜锚定形式的免疫原性比该蛋白的其他形式显著高(10至20倍)。

相似文献

1
Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.影响乳酸乳球菌中表达的破伤风毒素片段C免疫原性的因素。
FEMS Immunol Med Microbiol. 1996 Jun;14(2-3):167-77. doi: 10.1111/j.1574-695X.1996.tb00284.x.
2
Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge.乳酸乳球菌:破伤风毒素片段C的高水平表达及对致死性攻击的保护作用。
Mol Microbiol. 1993 Jun;8(6):1155-62. doi: 10.1111/j.1365-2958.1993.tb01660.x.
3
Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.两种重组乳酸菌经胃内给药后对破伤风毒素的保护作用:菌株活力和体内持久性的影响
Vaccine. 2002 Sep 10;20(27-28):3304-9. doi: 10.1016/s0264-410x(02)00301-8.
4
Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.用重组乳酸乳球菌对小鼠进行破伤风口服疫苗接种。
Nat Biotechnol. 1997 Jul;15(7):653-7. doi: 10.1038/nbt0797-653.
5
Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.用表达破伤风毒素片段C的重组乳酸乳球菌经鼻免疫小鼠后对破伤风毒素的保护作用。
Vaccine. 1997 Apr-May;15(6-7):616-9. doi: 10.1016/s0264-410x(96)00241-1.
6
Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.曼氏血吸虫的Sm14与破伤风毒素片段C融合可诱导小鼠对破伤风和血吸虫病产生免疫保护。
Infect Immun. 2004 Oct;72(10):5931-7. doi: 10.1128/IAI.72.10.5931-5937.2004.
7
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.用表达破伤风毒素片段C的重组戈登链球菌免疫可使小鼠免受致死性攻击。
Vaccine. 2001 Feb 28;19(15-16):1931-9. doi: 10.1016/s0264-410x(00)00434-5.
8
Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.表达破伤风毒素片段C的重组乳酸乳球菌菌株引发的黏膜和细胞免疫反应
Infect Immun. 2004 May;72(5):2753-61. doi: 10.1128/IAI.72.5.2753-2761.2004.
9
Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin.用表达破伤风毒素C片段的脊髓灰质炎病毒复制子免疫小鼠可使其免受破伤风毒素致死性攻击。
Vaccine. 1997 Feb;15(3):257-64. doi: 10.1016/s0264-410x(96)00187-9.
10
Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system.乳酸乳球菌作为重组黏膜疫苗递送系统的开发进展。
Folia Microbiol (Praha). 1995;40(3):225-30. doi: 10.1007/BF02814197.

引用本文的文献

1
Comparison of the immune effects of the MOMP antigen displayed in different parts of bacterial ghosts.细菌幽灵不同部位展示的主要外膜蛋白抗原免疫效果的比较。
Front Microbiol. 2024 Feb 7;15:1349746. doi: 10.3389/fmicb.2024.1349746. eCollection 2024.
2
Recombinant lactic acid bacteria as promising vectors for mucosal vaccination.重组乳酸菌作为黏膜疫苗的理想载体
Exploration (Beijing). 2021 Oct 30;1(2):20210026. doi: 10.1002/EXP.20210026. eCollection 2021 Oct.
3
Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health.
利用基因工程改造的乳酸菌和双歧杆菌作为人类和动物健康的活体传递载体。
Gut Microbes. 2022 Jan-Dec;14(1):2110821. doi: 10.1080/19490976.2022.2110821.
4
Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.破伤风毒素片段C:结构、药物发现研究与生产
Pharmaceuticals (Basel). 2022 Jun 17;15(6):756. doi: 10.3390/ph15060756.
5
The divergent roles of sortase in the biology of Gram-positive bacteria.分选酶在革兰氏阳性菌生物学中的不同作用。
Cell Surf. 2021 Jun 13;7:100055. doi: 10.1016/j.tcsw.2021.100055. eCollection 2021 Dec.
6
[Use of lactic acid bacteria as mucosal vaccines].[乳酸菌作为黏膜疫苗的应用]
Rev Francoph Lab. 2009 Dec;2009(417):79-89. doi: 10.1016/S1773-035X(09)70312-0. Epub 2009 Dec 11.
7
The Construction and Immunoadjuvant Activities of the Oral Interleukin-17B Expressed by NC8 Strain in the Infectious Bronchitis Virus Vaccination of Chickens.NC8株表达的口服白细胞介素-17B在鸡传染性支气管炎病毒疫苗接种中的构建及免疫佐剂活性
Vaccines (Basel). 2020 Jun 6;8(2):282. doi: 10.3390/vaccines8020282.
8
Genetics of Lactococci.乳球菌的遗传学。
Microbiol Spectr. 2019 Jul;7(4). doi: 10.1128/microbiolspec.GPP3-0035-2018.
9
Subcutaneous Immunization with Recombinant Expressing F1S1 Fusion Protein Induces Systemic and Mucosal Immune Responses in BALB/C Mice.用表达F1S1融合蛋白的重组体进行皮下免疫可诱导BALB/C小鼠产生全身和黏膜免疫反应。
Rep Biochem Mol Biol. 2019 Jan;7(2):196-203.
10
Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.用展示流感血凝素1(HA1)的非重组乳酸乳球菌进行口服免疫可诱导小鼠产生黏膜免疫。
PLoS One. 2017 Nov 6;12(11):e0187718. doi: 10.1371/journal.pone.0187718. eCollection 2017.